<DOC>
	<DOCNO>NCT00002281</DOCNO>
	<brief_summary>To evaluate safety , tolerance biological activity filgrastim ( granulocyte colony-stimulating factor ; G-CSF ) give daily subcutaneous ( SC ) injection prior concomitantly erythropoietin ( EPO ) zidovudine ( AZT ) patient AIDS severe AIDS relate complex ( ARC ) . To evaluate safety , tolerance , biological activity EPO give 3 time weekly SC injection concomitantly G-CSF prior concomitantly AZT patient AIDS severe ARC . To study safety tolerance 3 dose level AZT give patient AIDS severe ARC concomitantly treat G-CSF EPO . To study effect G-CSF alone combination EPO HIV replication vivo measure circulate HIV p24 antigen , plasma HIV viremia semiquantitative HIV cocultures .</brief_summary>
	<brief_title>A Study Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine Patients With AIDS AIDS-Related Complex</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>AIDS-Related Complex</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Treatment : Allowed : Radiation laser therapy Kaposi 's sarcoma lesion provide dose exceed 3000 rads one lesion group and/or great 10 cm2 total body surface area . Patients must : A diagnosis AIDS AIDS relate complex ( ARC ) define current CDC guideline . Life expectancy &gt; 6 month . Defined blood cell count may achieve transfusion . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : History malignancy Kaposi 's sarcoma ( KS ) . Presence &gt; 50 cutaneous KS lesion progression KS previous 30 day . Presence opportunistic infection require ongoing therapy know bone marrow suppressive agent . History cardiovascular disease . History seizure . HIV related dementia alter mental status would prohibit give understand informed consent . Presence iron deficiency anemia define serum ferritin &lt; 30 ng iron TIBC ratio &lt; 15 percent . A PT &gt; 15 PTT &gt; 40 unless due document circulate lupus anticoagulant . Concurrent Medication : Excluded : Trimethoprim / sulfamethoxazole . Fansidar . NonFDA approve antiretrovirals . Hyperimmunization polio virus . Ribavirin . Isoprinosine . Dextran sulfate . Fu zheng herb . AL 721 congener . Imuthiol . Interferons . Chronic use acyclovir ( &gt; 10 day 30 day ) . = &gt; 3g/day oral vitamin C. Patients follow exclude : Coexisting condition symptom describe Patient Exclusion Coexisting Conditions . Prior Medication : Excluded within 2 week study entry : Any nonFDA approved drug . Excluded within 4 week study entry : Systemic cytotoxic chemotherapy Kaposi 's sarcoma . Investigational agent . Excluded : Colony stimulate factor . Prior Treatment : Excluded within 4 week study entry : Radiation therapy Kaposi 's sarcoma exceeding 3000 rads one lesion group and/or great 10 cm2 total body surface area . Risk Behavior : Excluded within 3 month study entry : Regular excessive use alcohol , hallucinogens psychotropic agent possibly addict .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 1990</verification_date>
	<keyword>Injections , Subcutaneous</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>